Award recordCONTRACT

MCKESSON CORPORATION

PIID VA26113P0191· VHA· 261-NETWORK CONTRACT OFFICE 21· 6505 · DRUGS AND BIOLOGICALS· FY2013· $165,571 net obligations· UEI JTAPCFM4NSL4· CA

Description

DEOBLIGATION OF EXCESS FUNDS GAMNUEX-C 10% 10GM 100ML

Base award description: GAMNUEX-C 10% 10GM 100ML

First action · last action
2012-10-16 · 2013-10-17
Transactions
2
First transaction's obligation
$498,558
Base + all options value (sum of deltas)
$165,571
Extent competed
NOT COMPETED
Other than full & open authority
UNIQUE SOURCE
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
446110 · PHARMACIES AND DRUG STORES

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$498,558$0Base award · 2012-10-16 · this action $498,558 · running total $498,558Modification P00001 · 2013-10-17 · this action -$332,987 · running total $165,571
  • Base2012-10-16+$498,558= $498,558
  • Mod P000012013-10-17-$332,987= $165,571
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-10-16+$498,558$498,558GAMNUEX-C 10% 10GM 100ML
Mod P00001· FUNDING ONLY ACTION2013-10-17−$332,987$165,571DEOBLIGATION OF EXCESS FUNDS GAMNUEX-C 10% 10GM 100ML

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JTAPCFM4NSL4)

AwardOffice · PSC / listingNet obligationsFY
36C26024P0343260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$10,312FY2024
36C24824P0748248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$56,559FY2024
36C25724P0104257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$41,571FY2024
36C24724P0133247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$10,393FY2024
36C24824P0161248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$27,010FY2024
36C24823P2639248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$31,862FY2023

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26116F1413CSL BEHRING L.L.C.261-NETWORK CONTRACT OFFICE 21$12,789FY2016
VA26116F1244SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$31,450FY2016
VA26116F1240SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$7,234FY2016
VA26116F1408CSL BEHRING L.L.C.261-NETWORK CONTRACT OFFICE 21$10,733FY2016
VA26116F1213SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$62,900FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26113P0191_3600_-NONE-_-NONE- · retrieved 2026-09-26.